ResMed Inc (RMD)
243.60
+2.05
(+0.85%)
USD |
NYSE |
Nov 21, 16:00
244.95
+1.35
(+0.55%)
Pre-Market: 20:00
ResMed Shareholders Equity (Quarterly): 5.195B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 5.195B |
June 30, 2024 | 4.864B |
March 31, 2024 | 4.630B |
December 31, 2023 | 4.482B |
September 30, 2023 | 4.250B |
June 30, 2023 | 4.130B |
March 31, 2023 | 3.933B |
December 31, 2022 | 3.738B |
September 30, 2022 | 3.433B |
June 30, 2022 | 3.361B |
March 31, 2022 | 3.279B |
December 31, 2021 | 3.146B |
September 30, 2021 | 3.026B |
June 30, 2021 | 2.886B |
March 31, 2021 | 2.709B |
December 31, 2020 | 2.865B |
September 30, 2020 | 2.679B |
June 30, 2020 | 2.497B |
March 31, 2020 | 2.256B |
December 31, 2019 | 2.258B |
September 30, 2019 | 2.117B |
June 30, 2019 | 2.072B |
March 31, 2019 | 2.021B |
December 31, 2018 | 1.956B |
September 30, 2018 | 1.900B |
Date | Value |
---|---|
June 30, 2018 | 2.059B |
March 31, 2018 | 2.067B |
December 31, 2017 | 2.020B |
September 30, 2017 | 2.050B |
June 30, 2017 | 1.960B |
March 31, 2017 | 1.855B |
December 31, 2016 | 1.710B |
September 30, 2016 | 1.773B |
June 30, 2016 | 1.695B |
March 31, 2016 | 1.673B |
December 31, 2015 | 1.524B |
September 30, 2015 | 1.461B |
June 30, 2015 | 1.587B |
March 31, 2015 | 1.536B |
December 31, 2014 | 1.588B |
September 30, 2014 | 1.653B |
June 30, 2014 | 1.758B |
March 31, 2014 | 1.691B |
December 31, 2013 | 1.639B |
September 30, 2013 | 1.693B |
June 30, 2013 | 1.611B |
March 31, 2013 | 1.768B |
December 31, 2012 | 1.752B |
September 30, 2012 | 1.699B |
June 30, 2012 | 1.608B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.256B
Minimum
Mar 2020
5.195B
Maximum
Sep 2024
3.481B
Average
3.320B
Median
Shareholders Equity (Quarterly) Benchmarks
Boston Scientific Corp | 20.71B |
Globus Medical Inc | 4.069B |
Abbott Laboratories | 39.80B |
Haemonetics Corp | 878.85M |
Becton Dickinson & Co | 25.91B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.222B |
Total Liabilities (Quarterly) | 2.027B |
Debt to Equity Ratio | 0.1304 |
Current Ratio | 2.921 |
Net Debt Paydown Yield | 0.43% |